APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Nuclear Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Therapeutic Nuclear Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17404074032 January 2026196 pages

Choose your research edition.

Industry ResearchTherapeutic Nuclear Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Nuclear Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Therapeutic Nuclear Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Nuclear Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Nuclear Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Therapeutic Nuclear Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Nuclear Drug include Novartis, Dongcheng, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Therapeutic Nuclear Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Nuclear Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Nuclear Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Therapeutic Nuclear Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Nuclear Drug Segment by Company

Novartis

Dongcheng

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Nuclear Drug Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Nuclear Drug Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Nuclear Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Therapeutic Nuclear Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Therapeutic Nuclear Drug industry.

Chapter 3: Detailed analysis of Therapeutic Nuclear Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Nuclear Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Lutetium-177 Table 3. Key Players of Radium-223 Table 4. Key Players of Iodine-131 Table 3. Key Players of Other Table 4. Global Therapeutic Nuclear Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Lymphoma Table 6. Key Players of Thyroid Table 7. Key Players of Bone Metastasis Table 8. Key Players of Other Table 9. Global Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Therapeutic Nuclear Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Therapeutic Nuclear Drug Market Share by Region (2021-2026) Table 12. Global Therapeutic Nuclear Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Therapeutic Nuclear Drug Market Share by Region (2027-2032) Table 14. Therapeutic Nuclear Drug Industry Trends Table 15. Therapeutic Nuclear Drug Industry Drivers Table 16. Therapeutic Nuclear Drug Industry Opportunities and Challenges Table 17. Therapeutic Nuclear Drug Industry Restraints Table 18. Global Therapeutic Nuclear Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Therapeutic Nuclear Drug Revenue Market Share by Company (2021-2026) Table 20. Global Therapeutic Nuclear Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Therapeutic Nuclear Drug Key Company Head Office and Area Served Table 22. Global Therapeutic Nuclear Drug Company, Product Type & Application Table 23. Global Therapeutic Nuclear Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Therapeutic Nuclear Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Therapeutic Nuclear Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2021-2026) Table 30. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2027-2032) Table 31. Global Therapeutic Nuclear Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2021-2026) Table 35. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Therapeutic Nuclear Drug Product Portfolio Table 40. Novartis Recent Development Table 41. Dongcheng Company Information Table 42. Dongcheng Business Overview Table 43. Dongcheng Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Dongcheng Therapeutic Nuclear Drug Product Portfolio Table 45. Dongcheng Recent Development Table 46. Bayer Company Information Table 47. Bayer Business Overview Table 48. Bayer Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bayer Therapeutic Nuclear Drug Product Portfolio Table 50. Bayer Recent Development Table 51. Q BioMed Company Information Table 52. Q BioMed Business Overview Table 53. Q BioMed Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Q BioMed Therapeutic Nuclear Drug Product Portfolio Table 55. Q BioMed Recent Development Table 56. Mundipharma Company Information Table 57. Mundipharma Business Overview Table 58. Mundipharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Mundipharma Therapeutic Nuclear Drug Product Portfolio Table 60. Mundipharma Recent Development Table 61. Lantheus Company Information Table 62. Lantheus Business Overview Table 63. Lantheus Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Lantheus Therapeutic Nuclear Drug Product Portfolio Table 65. Lantheus Recent Development Table 66. Jubilant Radiopharma Company Information Table 67. Jubilant Radiopharma Business Overview Table 68. Jubilant Radiopharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Jubilant Radiopharma Therapeutic Nuclear Drug Product Portfolio Table 70. Jubilant Radiopharma Recent Development Table 71. International Isotopes Company Information Table 72. International Isotopes Business Overview Table 73. International Isotopes Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. International Isotopes Therapeutic Nuclear Drug Product Portfolio Table 75. International Isotopes Recent Development Table 76. Curium Pharmaceuticals Company Information Table 77. Curium Pharmaceuticals Business Overview Table 78. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Curium Pharmaceuticals Therapeutic Nuclear Drug Product Portfolio Table 80. Curium Pharmaceuticals Recent Development Table 81. China Isotope & Radiation Company Information Table 82. China Isotope & Radiation Business Overview Table 83. China Isotope & Radiation Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. China Isotope & Radiation Therapeutic Nuclear Drug Product Portfolio Table 85. China Isotope & Radiation Recent Development Table 86. Aurobindo Pharma Company Information Table 87. Aurobindo Pharma Business Overview Table 88. Aurobindo Pharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Aurobindo Pharma Therapeutic Nuclear Drug Product Portfolio Table 90. Aurobindo Pharma Recent Development Table 91. North America Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 92. North America Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 93. North America Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 94. North America Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 95. North America Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Therapeutic Nuclear Drug Market Size by Country (2021-2026) Table 97. North America Therapeutic Nuclear Drug Market Size by Country (2027-2032) Table 98. Europe Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 99. Europe Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 100. Europe Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 101. Europe Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 102. Europe Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Therapeutic Nuclear Drug Market Size by Country (2021-2026) Table 104. Europe Therapeutic Nuclear Drug Market Size by Country (2027-2032) Table 105. China Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 106. China Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 107. China Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 108. China Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 110. Asia Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 111. Asia Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 112. Asia Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Therapeutic Nuclear Drug Market Size by Country (2021-2026) Table 115. Asia Therapeutic Nuclear Drug Market Size by Country (2027-2032) Table 116. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021-2026) Table 122. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Therapeutic Nuclear Drug Product Image Figure 2. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Therapeutic Nuclear Drug Market Share by Type: 2025 VS 2032 Figure 4. Lutetium-177 Image Figure 5. Radium-223 Image Figure 6. Iodine-131 Image Figure 7. Other Image Figure 8. Global Therapeutic Nuclear Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Therapeutic Nuclear Drug Market Share by Application: 2025 VS 2032 Figure 10. Lymphoma Image Figure 11. Thyroid Image Figure 12. Bone Metastasis Image Figure 13. Other Image Figure 14. Global Therapeutic Nuclear Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Therapeutic Nuclear Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Therapeutic Nuclear Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Therapeutic Nuclear Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Therapeutic Nuclear Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Therapeutic Nuclear Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Therapeutic Nuclear Drug Market Share by Type (2021-2032) Figure 27. North America Therapeutic Nuclear Drug Market Share by Application (2021-2032) Figure 28. North America Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 29. United States Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Therapeutic Nuclear Drug Market Share by Type (2021-2032) Figure 34. Europe Therapeutic Nuclear Drug Market Share by Application (2021-2032) Figure 35. Europe Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 36. Germany Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Therapeutic Nuclear Drug Market Share by Type (2021-2032) Figure 44. China Therapeutic Nuclear Drug Market Share by Application (2021-2032) Figure 45. Asia Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Therapeutic Nuclear Drug Market Share by Type (2021-2032) Figure 47. Asia Therapeutic Nuclear Drug Market Share by Application (2021-2032) Figure 48. Asia Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 49. Japan Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 59. Brazil Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Dongcheng
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Lutetium-177
  5. 1.2.3 Radium-223
  6. 1.2.4 Iodine-131
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Lymphoma
  11. 1.3.3 Thyroid
  12. 1.3.4 Bone Metastasis
  13. 1.3.5 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Therapeutic Nuclear Drug Growth Trends by Region
  16. 1.5.1 Global Therapeutic Nuclear Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Therapeutic Nuclear Drug Market Size by Region (2021-2026)
  18. 1.5.3 Therapeutic Nuclear Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Therapeutic Nuclear Drug Market Dynamics
  1. 2.1 Therapeutic Nuclear Drug Industry Trends
  2. 2.2 Therapeutic Nuclear Drug Industry Drivers
  3. 2.3 Therapeutic Nuclear Drug Industry Opportunities and Challenges
  4. 2.4 Therapeutic Nuclear Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Therapeutic Nuclear Drug Revenue by Company (2021-2026)
  2. 3.2 Global Therapeutic Nuclear Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Therapeutic Nuclear Drug Key Company Head office and Area Served
  4. 3.4 Global Therapeutic Nuclear Drug Company, Product Type & Application
  5. 3.5 Global Therapeutic Nuclear Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Therapeutic Nuclear Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Therapeutic Nuclear Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Therapeutic Nuclear Drug Tier 1, Tier 2, and Tier 3
4 Therapeutic Nuclear Drug Market by Type
  1. 4.1 Global Therapeutic Nuclear Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Therapeutic Nuclear Drug Market Size by Type (2021-2032)
  3. 4.3 Global Therapeutic Nuclear Drug Market Size Share by Type (2021-2032)
5 Therapeutic Nuclear Drug Market by Application
  1. 5.1 Global Therapeutic Nuclear Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Therapeutic Nuclear Drug Market Size by Application (2021-2032)
  3. 5.3 Global Therapeutic Nuclear Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Therapeutic Nuclear Drug Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Dongcheng
  8. 6.2.1 Dongcheng Company Information
  9. 6.2.2 Dongcheng Business Overview
  10. 6.2.3 Dongcheng Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Dongcheng Therapeutic Nuclear Drug Product Portfolio
  12. 6.2.5 Dongcheng Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Therapeutic Nuclear Drug Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Q BioMed
  20. 6.4.1 Q BioMed Company Information
  21. 6.4.2 Q BioMed Business Overview
  22. 6.4.3 Q BioMed Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Q BioMed Therapeutic Nuclear Drug Product Portfolio
  24. 6.4.5 Q BioMed Recent Developments
  25. 6.5 Mundipharma
  26. 6.5.1 Mundipharma Company Information
  27. 6.5.2 Mundipharma Business Overview
  28. 6.5.3 Mundipharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Mundipharma Therapeutic Nuclear Drug Product Portfolio
  30. 6.5.5 Mundipharma Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lantheus Therapeutic Nuclear Drug Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 Jubilant Radiopharma
  38. 6.7.1 Jubilant Radiopharma Company Information
  39. 6.7.2 Jubilant Radiopharma Business Overview
  40. 6.7.3 Jubilant Radiopharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Jubilant Radiopharma Therapeutic Nuclear Drug Product Portfolio
  42. 6.7.5 Jubilant Radiopharma Recent Developments
  43. 6.8 International Isotopes
  44. 6.8.1 International Isotopes Company Information
  45. 6.8.2 International Isotopes Business Overview
  46. 6.8.3 International Isotopes Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 International Isotopes Therapeutic Nuclear Drug Product Portfolio
  48. 6.8.5 International Isotopes Recent Developments
  49. 6.9 Curium Pharmaceuticals
  50. 6.9.1 Curium Pharmaceuticals Company Information
  51. 6.9.2 Curium Pharmaceuticals Business Overview
  52. 6.9.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Curium Pharmaceuticals Therapeutic Nuclear Drug Product Portfolio
  54. 6.9.5 Curium Pharmaceuticals Recent Developments
  55. 6.10 China Isotope & Radiation
  56. 6.10.1 China Isotope & Radiation Company Information
  57. 6.10.2 China Isotope & Radiation Business Overview
  58. 6.10.3 China Isotope & Radiation Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 China Isotope & Radiation Therapeutic Nuclear Drug Product Portfolio
  60. 6.10.5 China Isotope & Radiation Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Therapeutic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Aurobindo Pharma Therapeutic Nuclear Drug Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
7 North America
  1. 7.1 North America Therapeutic Nuclear Drug Market Size (2021-2032)
  2. 7.2 North America Therapeutic Nuclear Drug Market Size by Type
  3. 7.2.1 North America Therapeutic Nuclear Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Therapeutic Nuclear Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Therapeutic Nuclear Drug Market Share by Type (2021-2032)
  6. 7.3 North America Therapeutic Nuclear Drug Market Size by Application
  7. 7.3.1 North America Therapeutic Nuclear Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Therapeutic Nuclear Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Therapeutic Nuclear Drug Market Share by Application (2021-2032)
  10. 7.4 North America Therapeutic Nuclear Drug Market Size by Country
  11. 7.4.1 North America Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Therapeutic Nuclear Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Therapeutic Nuclear Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Therapeutic Nuclear Drug Market Size (2021-2032)
  2. 8.2 Europe Therapeutic Nuclear Drug Market Size by Type
  3. 8.2.1 Europe Therapeutic Nuclear Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Therapeutic Nuclear Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Therapeutic Nuclear Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Therapeutic Nuclear Drug Market Size by Application
  7. 8.3.1 Europe Therapeutic Nuclear Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Therapeutic Nuclear Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Therapeutic Nuclear Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Therapeutic Nuclear Drug Market Size by Country
  11. 8.4.1 Europe Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Therapeutic Nuclear Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Therapeutic Nuclear Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Therapeutic Nuclear Drug Market Size (2021-2032)
  2. 9.2 China Therapeutic Nuclear Drug Market Size by Type
  3. 9.2.1 China Therapeutic Nuclear Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Therapeutic Nuclear Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Therapeutic Nuclear Drug Market Share by Type (2021-2032)
  6. 9.3 China Therapeutic Nuclear Drug Market Size by Application
  7. 9.3.1 China Therapeutic Nuclear Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Therapeutic Nuclear Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Therapeutic Nuclear Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Therapeutic Nuclear Drug Market Size (2021-2032)
  2. 10.2 Asia Therapeutic Nuclear Drug Market Size by Type
  3. 10.2.1 Asia Therapeutic Nuclear Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Therapeutic Nuclear Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Therapeutic Nuclear Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Therapeutic Nuclear Drug Market Size by Application
  7. 10.3.1 Asia Therapeutic Nuclear Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Therapeutic Nuclear Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Therapeutic Nuclear Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Therapeutic Nuclear Drug Market Size by Country
  11. 10.4.1 Asia Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Therapeutic Nuclear Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Therapeutic Nuclear Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst